The Amniotic Membrane Market to grow at a CAGR of 14.6% from 2022 to 2027| Amnio Technology LLC, Applied Biologics LLC, BIOHEALING SRO, and more to emerge as key players -Technavio

NEW YORK, July 17, 2023 /PRNewswire/ -- The amniotic membrane market size is estimated to grow by USD 2,298.09 million at a CAGR of 14.6% between 2022 and 2027, according to Technavio.The growing competition in the market is compelling vendors to adopt various growth strategies, such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market's competitive landscape and offers information on several market vendors, including - Amnio Technology LLC, Applied Biologics LLC, BIOHEALING SRO, Celularity Inc., Flower Orthopedics Corp., Human Regenerative Technologies LLC, Integra Lifesciences Corp., Katena Products Inc., Merakris Therapeutics Inc., MiMedx Group Inc., Next Biosciences Pty Ltd., NuVision Biotherapies Ltd, Organogenesis Holdings Inc., Orthofix Medical Inc., Reea carewell products, Skye Biologics Holdings LLC, Stryker Corp., Surgenex LLC, SURGITECH INNOVATION, and TissueTech Inc. - Download Sample Report in minutes.

Amniotic Membrane Market Insights -

• Vendors: 15+, Including Amnio Technology LLC, Applied Biologics LLC, BIOHEALING SRO, Celularity Inc., Flower Orthopedics Corp., Human Regenerative Technologies LLC, Integra Lifesciences Corp., Katena Products Inc., Merakris Therapeutics Inc., MiMedx Group Inc., Next Biosciences Pty Ltd., NuVision Biotherapies Ltd, Organogenesis Holdings Inc., Orthofix Medical Inc., Reea carewell products, Skye Biologics Holdings LLC, Stryker Corp., Surgenex LLC, SURGITECH INNOVATION, and TissueTech Inc., among others
• Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors
• Segments: end-user (hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutes), type (cryopreserved amniotic membrane and dehydrated amniotic membrane), and geography (North America, Europe, Asia, and Rest of World (ROW))

To understand more about the amniotic membrane market, request a sample report

Key Drivers-The extensive use of amniotic membrane transplantation in ophthalmic surgeries is a key factor driving market growth. The treatments related to ocular surface reconstruction have been highly transformed with the use of amniotic membrane transplantations.  This is due to the various characteristics of amniotic membranes which allow epithelial cells to migrate, strengthen cell adhesion, and encourage epithelial diffraction.

 Furthermore, the growing demand for using amniotic membrane transplantation among ophthalmologists to treat bullous keratitis, peripheral limbic stem cell deficiency, glaucoma or cataract, persistent epithelium defects, and corneoscleral ulcers. The demand for amniotic membranes among end-users such as hospitals and clinics is rising due to the increasing number of ophthalmic surgeries. Hence, this increasing demand among the end users is expected to drive market growth during the forecast period.

Major Trends- The growing reimbursement coverage for new products is a major trend in the market. There is a rapid increase in the modifications of reimbursement structures for new health products by governments throughout the world. This modification is to provide value-based care to the patients. Tissue-engineered products such as amniotic membranes are highly expensive. As a result, government organizations and market vendors are focusing on reimbursing such costs. Many suppliers are raising awareness of insurance coverage for different products among the end users by making information and guidance available on their websites. These activities reduce the cost of amniotic membranes and help patients to get treatment at a lower cost. Hence, this reimbursement coverage is expected to drive market growth during the forecast period.

Significant Challenges- The issues related to preservation and contamination are major challenges restricting the market growth. The fear of patients transmitting contagious diseases is restricting the end-users from adopting the amniotic fluid transfer procedure. Furthermore, an amniotic membrane is derived from amniotic sacs restored during cesarean and vaginal deliveries. These bacterial contaminants are commonly found in vaginal and placental areas that are responsible for contaminating the product. Vendors must regularly carry out serology checks at the time of storage of amniotic membranes to avoid any of these events. In addition, it is a challenging task for market vendors and end users to store the amniotic membrane while securing optimal conditions. This is majorly in emerging regions with a lack of advanced storage options. Hence, these factors are expected to restrict market growth during the forecast period.

Drivers, Trends & Challenges have an impact on market dynamics and can impact businesses. Find some insights from a sample report!

The amniotic membrane market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as prospects.

Why Buy?

• Add credibility to the strategy
• Analyzes competitor's offerings 
• Get a holistic view of the market
• Grow your profit margin with Technavio- Buy the Report

What are the key data covered in this Amniotic Membrane Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the amniotic membrane market between 2023 and 2027
• Precise estimation of the size of the amniotic membrane market and its contribution to the market with a focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the amniotic membrane market across North America, Europe, Asia, and the Rest of the World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of amniotic membrane market vendors

Gain instant access to 17,000+ market research reports. 

Technavio SUBSCRIPTION platform

Related Reports

The bioprocess validation market size is estimated to grow at a CAGR of 11.39% between 2022 and 2027. The market size is forecast to increase by USD 280.93 million. Furthermore, this report extensively covers market segmentation by end-user (pharmaceutical companies, contract development, manufacturing organizations, and others), type (in-house and outsourced), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The increasing demand for biopharmaceuticals is a key factor driving the market growth during the forecast period.

The cold plasma market is estimated to grow at a CAGR of 14.42% between 2022 and 2027. The market size is forecasted to increase by USD 1,790.8 million. Furthermore, this report extensively covers market segmentation by end-user (polymer and plastic industry, electronics and semiconductors industry, food and agriculture industry, textile industry, and medical industry), type (atmospheric cold plasma and low-pressure cold plasma), and geography (North America, Europe, Asia, and Rest of World (ROW)). The increasing demand for eco-friendly and sustainable technologies is a key factor driving the market growth during the forecast period.

Table of Contents

1 Executive Summary

• 1.1 Market Overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global amniotic membrane market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on global amniotic membrane market 2017 - 2021 ($ million)

• 4.2 Type Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)

• 4.3 End -user Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – End -user Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)

• 6.2 Comparison by End-user 
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user

• 6.3 Hospitals - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

• 6.4 Ambulatory surgical centers - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)

• 6.5 Specialty clinics - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Specialty clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Specialty clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Specialty clinics - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Specialty clinics - Year-over-year growth 2022-2027 (%)

• 6.6 Research and academic institutes - Market size and forecast 2022-2027 
• Exhibit 46: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)

• 6.7 Market opportunity by End-user 
• Exhibit 50: Market opportunity by End-user ($ million)
• Exhibit 51: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 52: Chart on Type - Market share 2022-2027 (%)
• Exhibit 53: Data Table on Type - Market share 2022-2027 (%)

• 7.2 Comparison by Type
• Exhibit 54: Chart on Comparison by Type
• Exhibit 55: Data Table on Comparison by Type

• 7.3 Cryopreserved amniotic membrane - Market size and forecast 2022-2027 
• Exhibit 56: Chart on Cryopreserved amniotic membrane - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Cryopreserved amniotic membrane - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Cryopreserved amniotic membrane - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Cryopreserved amniotic membrane - Year-over-year growth 2022-2027 (%)

• 7.4 Dehydrated amniotic membrane - Market size and forecast 2022-2027 
• Exhibit 60: Chart on Dehydrated amniotic membrane - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Dehydrated amniotic membrane - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Dehydrated amniotic membrane - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Dehydrated amniotic membrane - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Type 
• Exhibit 64: Market opportunity by Type ($ million)
• Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 67: Chart on Market share by geography 2022-2027 (%)
• Exhibit 68: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Canada - Market size and forecast 2022-2027 
• Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027 
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 UK - Market size and forecast 2022-2027 
• Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.11 France - Market size and forecast 2022-2027 
• Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 107: Market opportunity by geography ($ million)
• Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 109: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 114: Matrix on vendor position and classification

• 12.3 Amnio Technology LLC
• Exhibit 115: Amnio Technology LLC - Overview
• Exhibit 116: Amnio Technology LLC - Product / Service
• Exhibit 117: Amnio Technology LLC - Key offerings

• 12.4 Applied Biologics LLC 
• Exhibit 118: Applied Biologics LLC - Overview
• Exhibit 119: Applied Biologics LLC - Product / Service
• Exhibit 120: Applied Biologics LLC - Key offerings

• 12.5 BIOHEALING SRO
• Exhibit 121: BIOHEALING SRO - Overview
• Exhibit 122: BIOHEALING SRO - Product / Service
• Exhibit 123: BIOHEALING SRO - Key offerings

• 12.6 Celularity Inc.
• Exhibit 124: Celularity Inc. - Overview
• Exhibit 125: Celularity Inc. - Product / Service
• Exhibit 126: Celularity Inc. - Key news
• Exhibit 127: Celularity Inc. - Key offerings

• 12.7 Flower Orthopedics Corp. 
• Exhibit 128: Flower Orthopedics Corp. - Overview
• Exhibit 129: Flower Orthopedics Corp. - Product / Service
• Exhibit 130: Flower Orthopedics Corp. - Key offerings

• 12.8 Human Regenerative Technologies LLC 
• Exhibit 131: Human Regenerative Technologies LLC - Overview
• Exhibit 132: Human Regenerative Technologies LLC - Product / Service
• Exhibit 133: Human Regenerative Technologies LLC - Key offerings

• 12.9 Integra Lifesciences Corp. 
• Exhibit 134: Integra Lifesciences Corp. - Overview
• Exhibit 135: Integra Lifesciences Corp. - Business segments
• Exhibit 136: Integra Lifesciences Corp. - Key news
• Exhibit 137: Integra Lifesciences Corp. - Key offerings
• Exhibit 138: Integra Lifesciences Corp. - Segment focus

• 12.10 Katena Products Inc.
• Exhibit 139: Katena Products Inc. - Overview
• Exhibit 140: Katena Products Inc. - Product / Service
• Exhibit 141: Katena Products Inc. - Key news
• Exhibit 142: Katena Products Inc. - Key offerings

• 12.11 MiMedx Group Inc.
• Exhibit 143: MiMedx Group Inc. - Overview
• Exhibit 144: MiMedx Group Inc. - Business segments
• Exhibit 145: MiMedx Group Inc. - Key news
• Exhibit 146: MiMedx Group Inc. - Key offerings
• Exhibit 147: MiMedx Group Inc. - Segment focus

• 12.12 NuVision Biotherapies Ltd 
• Exhibit 148: NuVision Biotherapies Ltd - Overview
• Exhibit 149: NuVision Biotherapies Ltd - Product / Service
• Exhibit 150: NuVision Biotherapies Ltd - Key offerings

• 12.13 Organogenesis Holdings Inc. 
• Exhibit 151: Organogenesis Holdings Inc. - Overview
• Exhibit 152: Organogenesis Holdings Inc. - Product / Service
• Exhibit 153: Organogenesis Holdings Inc. - Key offerings

• 12.14 Orthofix Medical Inc. 
• Exhibit 154: Orthofix Medical Inc. - Overview
• Exhibit 155: Orthofix Medical Inc. - Business segments
• Exhibit 156: Orthofix Medical Inc. - Key offerings
• Exhibit 157: Orthofix Medical Inc. - Segment focus

• 12.15 Stryker Corp.
• Exhibit 158: Stryker Corp. - Overview
• Exhibit 159: Stryker Corp. - Business segments
• Exhibit 160: Stryker Corp. - Key news
• Exhibit 161: Stryker Corp. - Key offerings
• Exhibit 162: Stryker Corp. - Segment focus

• 12.16 Surgenex LLC
• Exhibit 163: Surgenex LLC - Overview
• Exhibit 164: Surgenex LLC - Product / Service
• Exhibit 165: Surgenex LLC - Key offerings

• 12.17 TissueTech Inc.
• Exhibit 166: TissueTech Inc. - Overview
• Exhibit 167: TissueTech Inc. - Product / Service
• Exhibit 168: TissueTech Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 169: Inclusions checklist
• Exhibit 170: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 171: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 172: Research methodology
• Exhibit 173: Validation techniques employed for market sizing
• Exhibit 174: Information sources

• 13.5 List of abbreviations
• Exhibit 175: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio